Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies
Abstract The initial management of rheumatoid arthritis (RA) has a high impact on disease prognosis. Therefore, we need to select the most appropriate treatment as soon as possible. This goal requires biomarkers of disease severity and prognosis. One such biomarker may be the presence of anti-carbam...
Enregistré dans:
Auteurs principaux: | Cristina Regueiro, Laura Nuño, Ana Triguero-Martinez, Ana M. Ortiz, Alejandro Villalba, María Dolores Bóveda, Ana Martínez-Feito, Carmen Conde, Alejandro Balsa, Isidoro González-Alvaro, Antonio Gonzalez |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b6491be058124b308159c5caeeafb49e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
par: Cristina Regueiro, et autres
Publié: (2017) -
Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis.
par: Jeroen N Stoop, et autres
Publié: (2014) -
Clinical utility of anti-carbamylated antibody in rheumatoid arthritis female patients: Emerging predictive value compared to anti-cyclic citrullinated peptide and rheumatoid factor
par: Ahmed E. Hafez, et autres
Publié: (2022) -
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence
par: Iacono D, et autres
Publié: (2018) -
The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis
par: Sara Fuentelsaz-Romero, et autres
Publié: (2021)